Dysregulation of hepatocyte growth factor/mesenchymal-epithelial transition factor gene (HGF/c-MET) pathway plays a crucial role in human carcinogenesis, tumor progression and resistance to antineoplastic treatments. Here, MET is linked to neoplasm.